Edition:
United States

Abiomed Inc (ABMD.O)

ABMD.O on Nasdaq

136.64USD
2:00pm EDT
Change (% chg)

$1.74 (+1.29%)
Prev Close
$134.90
Open
$135.33
Day's High
$136.74
Day's Low
$134.39
Volume
154,643
Avg. Vol
354,690
52-wk High
$137.00
52-wk Low
$95.14

ABMD.O

Chart for ABMD.O

About

ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops,... (more)

Overall

Beta: 0.25
Market Cap(Mil.): $5,891.53
Shares Outstanding(Mil.): 43.67
Dividend: --
Yield (%): --

Financials

  ABMD.O Industry Sector
P/E (TTM): 116.17 44.49 17.42
EPS (TTM): 1.16 -- --
ROI: 12.15 8.91 -5.45
ROE: 12.70 13.91 -4.73

BRIEF-Abiomed says enrolled first patient in FDA approved prospective feasibility study

* Abiomed - enrollment of first patient in fda approved prospective feasibility study, STEMI door to unloading with Impella CP system in acute myocardial infarction

May 04 2017

BRIEF-Abiomed Q4 gaap earnings per share $0.33

* Abiomed announces Q4 fy 2017 revenue of $124.7 million, up 33% over prior year and total year revenue of $445.3 million, up 35% over prior year

May 04 2017

BRIEF-Abiomed announces Q4 revenue of $124.7 million, up 33 pct

* Abiomed announces q4 fy 2017 revenue of $124.7 million, up 33% over prior year and total year revenue of $445.3 million, up 35% over prior year

May 04 2017

BRIEF-Abiomed Q3 GAAP earnings per share $0.34

* Abiomed announces Q3 FY 2017 revenue of $114.7 million, up 34% over prior year

Jan 26 2017

BRIEF-Abiomed Q3 earnings per share $0.34

* Says increasing lower end of its fiscal year 2017 revenue guidance with new range of $440 million to $445 million

Jan 26 2017

BRIEF-Abiomed announces preliminary q3 preliminary revenue

* Abiomed announces preliminary q3 fy 2017 revenue of $114.7 million, up 34% over prior year

Jan 09 2017

More From Around the Web

Earnings vs. Estimates